Drug
Yangxinshi tablet
Yangxinshi tablet is a pharmaceutical drug with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph phase_4
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
3(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Other(1)
Detailed Status
Recruiting2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 43 (100.0%)
Trials by Status
unknown133%
recruiting267%
Recent Activity
2 active trials
Showing 3 of 3
recruitingphase_4
Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction
NCT07110415
recruitingphase_4
Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome
NCT06171061
unknownphase_4
Effect of Yangxinshi Tablet on Exercise Tolerance in Patients With Chronic Coronary Syndrome（MET STUDY）
NCT05978089
Clinical Trials (3)
Showing 3 of 3 trials
NCT07110415Phase 4
Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction
NCT06171061Phase 4
Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome
NCT05978089Phase 4
Effect of Yangxinshi Tablet on Exercise Tolerance in Patients With Chronic Coronary Syndrome（MET STUDY）
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3